Diabetic Retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels in the light-sensitive tissue at the back of the eye (retina). The condition can progressively worsen and potentially lead to blindness. Treatment options include: Focal/Grid Laser Photocoagulation, Intravitreal Injections (Anti-VEGF agents or Corticosteroids), and Vitrectomy. These interventions aim to reduce the risk of vision loss and improve overall visual function.
Diabetic Retinopathy is a complication of diabetes that affects the eyes. It's caused by damage to the blood vessels in the light-sensitive tissue at the back of the eye (retina). The condition can progressively worsen and potentially lead to blindness. Treatment options include: Focal/Grid Laser Photocoagulation, Intravitreal Injections (Anti-VEGF agents or Corticosteroids), and Vitrectomy. These interventions aim to reduce the risk of vision loss and improve overall visual function.
Diabetic Retinopathy is treated via Intravitreal injections of anti-vascular endothelial growth factor (Avastin or Lucentis) or laser photocoagulation. Spain's public healthcare system covers these treatments.
Waiting times can vary from 1 to 3 months for initial appointment and treatment.